Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim launches 'gamified' COPD initiative

Programme aims to encourage and reward disease management
Boehringer Ingelheim

Boehringer Ingelhiem has launched a gamified support programme to help people living with chronic obstructive pulmonary disease (COPD) manage their disease.

The company says the free, online programme, for which it has partnered with HealthPrize, is a first for pharma as it seeks to offer follow-up services for patients prescribed its Spiriva Respimat treatment.

The RespiPoints programme encourages patients to meet treatment goals by reporting on taking medication, verifying their monthly refills and reading educational materials on COPD.

Points can be earned by completing each of these tasks - as well as taking part in quizzes and surveys on the site - which are redeemable as e-gift cards.

Boehringer Ingelheim hopes the programme will improve the currently poor adherence to treatment plans that is common among people with COPD, often resulting in increased adverse symptoms, healthcare costs and hospitalisation.

Ruchin Kansal, business innovation lead at Boehringer, said that the company is “proud to continue our unwavering commitment to the COPD community with new technology and support services that can help improve patient outcomes”.

“The RespiPoints programme is the latest in a series of efforts to empower people living with COPD to better manage their health with tools that are engaging and educational,” he added.

Boehringer Ingelheim recently signed a digital health deal with Propeller Health to help track how patients use inhaled medications.

The digital platform will utilise apps, analytics, educational materials and feedback to gather data on adherence rates and so gain a greater understanding of patient engagement with COPD treatment.

Article by
Rebecca Clifford

16th June 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...